Quick Answer
WINDTREE THERAPEUTICS INC /DE/ reported R&D Expense of $16.28 million for fiscal year 2024.
WINDTREE THERAPEUTICS INC /DE/ R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $16.28M | +95.1% |
| 2023 | $8.34M | -24.8% |
| 2022 | $11.10M | -37.6% |
| 2021 | $17.79M | +15.7% |
| 2020 | $15.37M | +21.2% |
| 2019 | $12.69M | +20.1% |
| 2018 | $10.56M | -39.2% |
| 2017 | $17.38M | -45.2% |
| 2016 | $31.70M | +9.8% |
| 2015 | $28.89M | +8.2% |
| 2014 | $26.69M | -3.5% |
| 2013 | $27.66M | +28.2% |
| 2012 | $21.57M | +25.2% |
| 2011 | $17.23M | +0.5% |
| 2010 | $17.14M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.90M | -3.6% | -13.1% |
| June 30, 2025 | $2.18M | -77.9% | -3.9% |
| March 31, 2025 | $2.27M | +0.8% | +15.3% |
| September 30, 2024 | $1.97M | -6.7% | -80.0% |
| June 30, 2024 | $9.86M | +459.4% | +337.8% |
| March 31, 2024 | $2.25M | +59.2% | +6.8% |
| September 30, 2023 | $2.11M | +36.7% | +19.7% |
| June 30, 2023 | $1.76M | -41.1% | +24.6% |
- WINDTREE THERAPEUTICS INC /DE/ showed an increase of +95.1% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2024 period, WINDTREE THERAPEUTICS INC /DE/’s r&d expense has declined by 5.0% (from $17.14 million to $16.28 million).
- The most recent figure is from WINDTREE THERAPEUTICS INC /DE/’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: